Variable | Category | n (%) |
---|---|---|
Gender | Male | 32 (31.7) |
Female | 69 (68.3) | |
Age (years) | 29–91 (66.0) | |
Stage | High-risk stage II | 49 (48.5) |
Stage III | 52 (51.5) | |
Histological grade | G1 | 23 (23.0) |
G2 | 74 (74.0) | |
G3 | 3 (3.0) | |
Vascular invasion | No | 86 (85.2) |
Yes | 15 (14.8) | |
Perineural invasion | No | 80 (79.2) |
Yes | 21 (20.8) | |
Lymphatic invasion | No | 75 (74.3) |
Yes | 26 (25.7) | |
Adjuvant chemotherapy | No | 47 (46.5) |
Yes | 54 (53.5) | |
VEGF | Negative | 18 (17.8) |
Positive | 83 (82.2) | |
HIF1A | Negative | 27 (26.7) |
Positive | 74 (73.3) | |
PPARG | Negative | 58 (57.4) |
Positive | 43 (42.6) | |
LXRA | Negative | 66 (66.0) |
Positive | 34 (34.0) | |
LXRB | Negative | 3 (3.0) |
Positive | 98 (97.0) |